These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 31830937)
1. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients. Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937 [TBL] [Abstract][Full Text] [Related]
2. Hypermethylated Promoters of Secreted Frizzled-Related Protein Genes are Associated with Colorectal Cancer. Hu H; Wang T; Pan R; Yang Y; Li B; Zhou C; Zhao J; Huang Y; Duan S Pathol Oncol Res; 2019 Apr; 25(2):567-575. PubMed ID: 30368728 [TBL] [Abstract][Full Text] [Related]
3. Coexpression of SFRP1 and WIF1 as a prognostic predictor of favorable outcomes in patients with colorectal carcinoma. Huang S; Zhong X; Gao J; Song R; Wu H; Zi S; Yang S; Du P; Cui L; Yang C; Li Z Biomed Res Int; 2014; 2014():256723. PubMed ID: 24949429 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer. Liu S; Chen X; Chen R; Wang J; Zhu G; Jiang J; Wang H; Duan S; Huang J Oncotarget; 2017 May; 8(22):36354-36367. PubMed ID: 28422739 [TBL] [Abstract][Full Text] [Related]
5. Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients. Rawson JB; Manno M; Mrkonjic M; Daftary D; Dicks E; Buchanan DD; Younghusband HB; Parfrey PS; Young JP; Pollett A; Green RC; Gallinger S; McLaughlin JR; Knight JA; Bapat B Carcinogenesis; 2011 May; 32(5):741-7. PubMed ID: 21304055 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma. Kumar A; Gosipatala SB; Pandey A; Singh P Asian Pac J Cancer Prev; 2019 May; 20(5):1571-1577. PubMed ID: 31128064 [TBL] [Abstract][Full Text] [Related]
7. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer. Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433 [TBL] [Abstract][Full Text] [Related]
8. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas. Paluszczak J; Hemmerling D; Kostrzewska-Poczekaj M; Jarmuż-Szymczak M; Grenman R; Wierzbicka M; Baer-Dubowska W J Oral Pathol Med; 2014 Oct; 43(9):652-7. PubMed ID: 24762262 [TBL] [Abstract][Full Text] [Related]
9. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. Qi J; Zhu YQ; Luo J; Tao WH World J Gastroenterol; 2006 Nov; 12(44):7113-7. PubMed ID: 17131472 [TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer. Veeck J; Wild PJ; Fuchs T; Schüffler PJ; Hartmann A; Knüchel R; Dahl E BMC Cancer; 2009 Jul; 9():217. PubMed ID: 19570204 [TBL] [Abstract][Full Text] [Related]
11. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance. Boughanem H; Pilo J; García-Flores LA; Arranz I; Ramos-Fernandez M; Ortega-Castan M; Crujeiras AB; Sandoval J; Macias-Gonzalez M J Transl Med; 2024 May; 22(1):509. PubMed ID: 38802858 [TBL] [Abstract][Full Text] [Related]
12. DNA hypermethylation of Liu X; Bi H; Ge A; Xia T; Fu J; Liu Y; Sun H; Li D; Zhao Y Transl Cancer Res; 2019 Sep; 8(5):1985-1996. PubMed ID: 35116947 [TBL] [Abstract][Full Text] [Related]
13. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma. Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013 [TBL] [Abstract][Full Text] [Related]
14. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas. Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530 [TBL] [Abstract][Full Text] [Related]
15. Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists. Silva AL; Dawson SN; Arends MJ; Guttula K; Hall N; Cameron EA; Huang TH; Brenton JD; Tavaré S; Bienz M; Ibrahim AE BMC Cancer; 2014 Nov; 14():891. PubMed ID: 25432628 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the DNA methylation level of cancer-related genes in colorectal cancer and the surrounding normal mucosa. Sugai T; Yoshida M; Eizuka M; Uesugii N; Habano W; Otsuka K; Sasaki A; Yamamoto E; Matsumoto T; Suzuki H Clin Epigenetics; 2017; 9():55. PubMed ID: 28533824 [TBL] [Abstract][Full Text] [Related]
17. [Hypermethylation and regulation of expression of secreted frizzled-related protein genes in colorectal tumor]. Qi J; Zhu YQ; Luo J; Tao WH; Zhang JM Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):842-5. PubMed ID: 18396643 [TBL] [Abstract][Full Text] [Related]
18. Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples. Barták BK; Kalmár A; Péterfia B; Patai ÁV; Galamb O; Valcz G; Spisák S; Wichmann B; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Molnár B Epigenetics; 2017 Sep; 12(9):751-763. PubMed ID: 28753106 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia. Dhir M; Montgomery EA; Glöckner SC; Schuebel KE; Hooker CM; Herman JG; Baylin SB; Gearhart SL; Ahuja N J Gastrointest Surg; 2008 Oct; 12(10):1745-53. PubMed ID: 18716850 [TBL] [Abstract][Full Text] [Related]
20. The detection of specific hypermethylated WIF1 and NPY genes in circulating DNA by crystal digital PCR™ is a powerful new tool for colorectal cancer diagnosis and screening. Overs A; Flammang M; Hervouet E; Bermont L; Pretet JL; Christophe B; Selmani Z BMC Cancer; 2021 Oct; 21(1):1092. PubMed ID: 34627187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]